5-Carboxylcytosine levels are elevated in human breast cancers and gliomas

Clinical Epigenetics

Alexey Ruzov¹  Srinivasan Madhusudan²  Ian O. Ellis⁸  Dorothee T. Auer³  Andrew D. Johnson⁵  Arvind Arora⁷  Abdulkadir Abakir⁶  Christina Perry²  Lee M. Wheldon⁴  Ana Jimenez Pascual¹  Maria Eleftheriou¹ 

[1] Division of Cancer and Stem Cells, School of Medicine, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK;Academic Unit of Oncology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK;Department of Academic Radiology, Queen’s Medical Centre, Nottingham University Hospitals, University of Nottingham, Nottingham NG7 2UH, UK;Medical Molecular Sciences, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK;School of Life Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK;Present address: Lab de Neurophysiologie, Université libre de Bruxelles, Campus Erasme CP 601, Bldg. C Room C3-143, 808, Route de Lennik, Brussels, B-1070, Belgium;Department of Oncology, Nottingham University Hospitals, Nottingham NG5 1PB, UK;Department of Pathology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham NG51PB, UK

关键词: Immunohistochemistry;    Breast cancer;    Carcinogenesis;    5-carboxylcytosine;    5-hydroxymethylcytosine;    DNA methylation;   

Others  :  1225871
DOI  :  10.1186/s13148-015-0117-x

 received in 2015-05-07, accepted in 2015-07-24,  发布年份 2015

【 摘 要 】

Background

DNA methylation (5-methylcytosine (5mC)) patterns are often altered in cancers. Ten-eleven translocation (Tet) proteins oxidise 5mC to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). In addition to their presumptive specific biological roles, these oxidised forms of 5mC may serve as intermediates in demethylation process. According to several reports, 5hmC levels are strongly decreased in cancers; however, the distribution of 5fC and 5caC in malignant tissue has not been studied.

Findings

Here, we examine the levels of 5hmC and 5caC in 28 samples of normal breast tissue, 59 samples of invasive human breast cancer and 74 samples of gliomas using immunochemistry. In agreement with previous reports, we show that 71 % of normal breast samples exhibit strong 5hmC signal, compared with only 18 % of breast cancer samples with equivalent levels of 5hmC staining. Unexpectedly, although 5caC is not detectable in normal breast tissue, 27 % of breast cancer samples exhibit significant staining for this modification (p < 0.001). Surprisingly, the presence of immunochemically detectable 5caC is not associated with the intensity of 5hmC signal in breast cancer tissue. In gliomas, we show that 5caC is detectable in 45 % of tumours.

Conclusions

We demonstrate that, unlike 5hmC, the levels of 5caC are elevated in a proportion of breast cancers and gliomas. Our results reveal another level of complexity to the cancer epigenome, suggesting that active demethylation and/or 5caC-dependent transcriptional regulation are pre-activated in some tumours and may contribute to their pathogenesis. Larger studies to evaluate the clinicopathological significance of 5caC in cancers are warranted.

【 授权许可】

   
2015 Eleftheriou et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Schübeler D: Function and information content of DNA methylation. Nature 2015, 7534:321-6.
• [2]Goding CR, Pei D, Lu X: Cancer: pathological nuclear reprogramming? Nat Rev Cancer 2014, 14:568-73.
• [3]Ehrlich M, Lacey M: DNA hypomethylation and hemimethylation in cancer. Adv Exp Med Biol 2013, 754:31-56.
• [4]Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, et al.: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 5929:930-5.
• [5]He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, et al.: Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 6047:1303-7.
• [6]Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, et al.: Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 6047:1300-3.
• [7]Ficz G, Hore TA, Santos F, Lee HJ, Dean W, Arand J, et al.: FGF signaling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency. Cell Stem Cell 2013, 13:351-9.
• [8]Iurlaro M, Ficz G, Oxley D, Raiber EA, Bachman M, Booth MJ, et al.: A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol 2013, 14:R119. BioMed Central Full Text
• [9]Haffner MC, Chaux A, Meeker AK, Esopi DM, Gerber J, Pellakuru LG, et al.: Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-37.
• [10]Jin SG, Jiang Y, Qiu R, Rauch TA, Wang Y, Schackert G, et al.: 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 2011, 71:7360-5.
• [11]Kudo Y, Tateishi K, Yamamoto K, Yamamoto S, Asaoka Y, Ijichi H, et al.: Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation. Cancer Sci 2012, 103:670-6.
• [12]Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, et al.: Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-46.
• [13]Maiti A, Drohat AC: Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J Biol Chem 2011, 286:35334-8.
• [14]Wheldon LM, Abakir A, Ferjentsik Z, Dudnakova T, Strohbuecker S, Christie D, Dai N, Guan S, Foster JM, Corrêa IR Jr, Loose M, Dixon JE, Sottile V, Johnson AD, Ruzov A: Transient accumulation of 5-carboxylcytosine indicates involvement of active demethylation in lineage specification of neural stem cells. Cell Rep 2014, 7:1353-61.
• [15]Almeida RD, Loose M, Sottile V, Matsa E, Denning C, Young L, et al.: 5-hydroxymethyl-cytosine enrichment of non-committed cells is not a universal feature of vertebrate development. Epigenetics 2012, 7:383-9.
• [16]Almeida RD, Sottile V, Loose M, De Sousa PA, Johnson AD, Ruzov A: Semi-quantitative immunohistochemical detection of 5-hydroxymethyl-cytosine reveals conservation of its tissue distribution between amphibians and mammals. Epigenetics 2012, 7:137-40.
• [17]Chowdhury B, Cho IH, Hahn N, Irudayaraj J: Quantification of 5-methylcytosine, 5-hydroxymethylcytosine and 5-carboxylcytosine from the blood of cancer patients by an enzyme-based immunoassay. Anal Chim Acta 2014, 852:212-7.